Evidence map›Paper›PMID 27580936›Full record

ArticleScientific reports2016

Inhibition of caspase-9 aggravates acute liver injury through suppression of cytoprotective autophagy.

Rui Guo, Bin Lin, Jing Fei Pan, Emily C Liong, Ai Min Xu, Moussa Youdim, Man Lung Fung, Kwok Fai So, George L Tipoe

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Protective Effects ofMolecules (Basel, Switzerland) · 2022
    Article
  5. Article
  6. 5-O-Demethylnobiletin Alleviates CClInternational journal of molecular sciences · 2021
    Article
  7. Article
  8. Deficiency of miR-208a Exacerbates CClHepatology communications · 2020
    Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Rui GuoSchool of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, SAR, Hong Kong.
Bin LinSchool of Optometry, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, SAR, Hong Kong.
Jing Fei PanSchool of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, SAR, Hong Kong.
Emily C LiongSchool of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, SAR, Hong Kong.
Ai Min XuBrain Hormone Healthy Aging Centre, LKS Faculty of Medicine, The University of Hong Kong, SAR, Hong Kong.
Moussa YoudimFaculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Man Lung FungSchool of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, SAR, Hong Kong.
Kwok Fai SoSchool of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, SAR, Hong Kong.
George L TipoeSchool of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, SAR, Hong Kong.
University of Hong Kong · HKHong Kong Polytechnic University · HKTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute liver disease is characterized by inflammation, oxidative stress and necrosis, which can greatly influence the long term clinical outcome and lead to liver failure or cancer. Here, we initially demonstrated the beneficial role of caspase-9-dependent autophagy in acute liver injury. Treatment with caspase-9 inhibitor z-LEHD-FMK in HepG2 cells, AML12 cells and C57BL/b6N mice exacerbated CCl4-induced acute hepatocellular damage, and also down-regulated autophagy markers expression levels, indicating that caspase-9 inhibition may aggravate acute liver damage by suppressing cytoprotective autophagy. CCl4 was used as an acute liver injury inducer which caused oxidative stress and apoptosis through up-regulation of HIF-1α, as well as triggered hepatic inflammation and necroptosis via TLR4/NF-κB pathway. Caspase-9 Thr125 site was firstly phosphorylated by ERK1/2 which subsequently activated the cytoprotective autophagy process to attenuate acute CCl4 injury. Caspase-9 inhibition further aggravated hepatic necroptosis through NF-κB expression, leading to increased pro-inflammatory mediators levels, suggesting a protective role of caspase-9-dependent autophagy in the inflammatory process as well as its possibility being a new therapeutic target for the treatment of acute liver injury.

Indexed as

AnimalsAutophagyCarbon TetrachlorideCaspase 9Chemical and Drug Induced Liver InjuryFemaleGene Expression RegulationHep G2 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiceMice, Inbred C57BLMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NF-kappa Bbenzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketoneCarbon TetrachlorideCasp9 protein, mouseCaspase 9Hif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitMapk1 protein, mouseMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NF-kappa BOligopeptidesThreonineTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID27580936
PMCPMC5007529
OpenAlexW2518481037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.